TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)

1 month ago 34

Lantheus Holdings, Inc. (NASDAQ:LNTH) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.

TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)

TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)

Lantheus Holdings, Inc. (NASDAQ:LNTH) is fixed the 4th presumption connected our database of cheap pharmaceutical stocks.

TheFly reported connected January 29 that TD Cowen lowered its terms people connected LNTH to $75 from $80 and gave it a Buy rating. The steadfast besides updated its fiscal exemplary successful anticipation of the company’s upcoming fourth-quarter results.

Earlier, connected January 2, Lantheus Holdings, Inc. (NASDAQ:LNTH) officially announced the completion of its antecedently planned divestiture of the Single Photon Emission Computed Tomography (SPECT) concern to SHINE Technologies. LNTH' diagnostic agents, the SPECT merchandise manufacturing country of its North Billerica, Massachusetts site, and SPECT-related activities successful Canada were each included successful the sale. LNTH whitethorn reorganize its operations and ore connected regions with much maturation imaginable and profits acknowledgment to this strategical transaction.

The company's maturation of its commercialized portfolio successful PET radiodiagnostics, which comprises blase imaging solutions, and its microbubble products utilized successful contrast-enhanced ultrasound procedures, volition beryllium its apical priorities going forward. In bid to presumption the concern for semipermanent maturation successful precision imaging and targeted treatments, LNTH volition simultaneously support investing successful and processing its pipeline of radiopharmaceuticals. The institution volition usage its cognition of atomic medicine to make caller diagnostic and therapeutic solutions for patients.

Lantheus Holdings, Inc. (NASDAQ:LNTH) is simply a U.S. radiopharmaceutical person processing and commercializing innovative precision diagnostics and oncology imaging agents that assistance clinicians observe and show disease.

While we admit the imaginable of LNTH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.

Disclosure: None.

Read Entire Article